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Can perioperative hemodilution be
monitored with non-invasive measurement
of blood hemoglobin?
Robert G. Hahn1* , Patrick Y. Wuethrich2 and Joachim H. Zdolsek3
Abstract
Background: Trends in non-invasive measurements of blood hemoglobin (Hb) may be useful for identifying the
need for transfusion in the perioperative period.
Methods: Crystalloid fluid (5–20 mL/kg) was administered intravenously or by mouth to 30 volunteers and 33
surgical patients in five non-randomized clinical studies where Hb was measured on 915 occasions by non-invasive
(Radical-7™) and invasive methodology. The hemodilution curves were compared by volume kinetic analysis and
linear regression, with the slope and scattering of the data as key outcome measures.
Results: The slope was 1.0, indicating unity between the two modes of measuring Hb when crystalloid fluid was
infused in volunteers; however, only 40–45% of the variability in the non-invasive Hb could be explained by the
invasive Hb. Patients undergoing major surgery, who showed the most pronounced hemodilution (median 24 g/L);
non-invasive Hb explained 72% of the variability but indicated only half the magnitude of the invasive Hb changes
(slope 0.48, P < 0.001 versus the volunteers). Simulations based on volume kinetic parameters from the volunteers
showed 25% less plasma volume expansion after infusion when based on non-invasive as compared to invasive Hb,
while no difference was found during infusion.
Conclusions: In volunteers the non-invasive Hb had good accuracy (low bias) but poor precision. In surgical
patients the non-invasive Hb had good precision but systematically underestimated the hemodilution. Despite
severe limitations, the non-invasive technology can be used to follow Hb trends during surgery if supported by
occasional invasive measurements to assure acceptable quality of the hemodilution curve.
Trial registrations: ControlledTrials.gov NCT01195025, NCT01062776, NCT01458678, NCT03848507, and
NCT01360333 on September 3, 2010, February 4, 2010, October 25, 2011, February 20, 2019, and May 25, 2011,
respectively.
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Background
The measurement of the blood hemoglobin (Hb) con-
centration is a guide that determines when transfusion
of erythrocytes should be initiated. Sporadic measure-
ment of Hb is often performed during major surgery to
evaluate when the Hb value corresponding to the “trans-
fusion trigger” is reached. Continuous measurement of
Hb would therefore be of substantial value to refine
these decisions. For this purpose, non-invasive Hb ana-
lysis has been commercially available for about a decade
in the form of the multi-wavelength pulse oximeter
Radical-7™ from Masimo Inc.
Many studies have performed point-wise comparisons
between non-invasive and invasive Hb [1–13], and the
main problem with the non-invasive technology is its
poor precision. Several studies show good accuracy but
95% limits of agreement with a range of 40 g/L or more
[3–9], which makes non-invasive Hb measurements dif-
ficult to rely on.
A more essential clinical question is whether the
changes in Hb agree over time in an individual patient.
If this is the case, the pulse oximeter could be calibrated
with the known invasive Hb when surgery starts and
then be used to indicate relative changes. To study this
possibility, we reviewed the linearity between changes in
Hb level as given by non-invasive and invasive Hb moni-
toring, using data from five cohorts where the Hb level
had shifted due to fluid therapy and/or hemorrhage.
The aim of the present report was to determine the re-
liability of the non-invasive Hb for tracking changes in
invasive Hb. Our hypothesis was that the non-invasive
alternative is a useful index of Hb changes. This issue
was studied by direct comparisons of Hb trends and also
by assessing kinetic analyses of plasma volume shifts
based on either mode of Hb measurement.
Methods
Data from five case non-randomized clinical trials where
the Hb concentration was altered by intravenous or oral
administration of crystalloid fluid with and without
hemorrhage was reviewed. All studies were approved by
the appropriate local Ethics committee and were regis-
tered at ClinicalTrials.gov before any patient was re-
cruited. This report adheres to the CONSORT
guidelines.
Procedures
The five series comprised only euhydrated subjects.
Study 1 included the infusions of 25 mL kg− 1 of
Ringer’s solution given 10 healthy male volunteers [11].
Study 2 evaluated the ability of volume kinetics to
detect deliberately induced dehydration; here, only the
10 control infusions of 10 mL kg− 1 of Ringer’s were
used [12].
Study 3 used repeated Hb sampling during a short
infusion of 5 mL kg− 1 of Ringer’s in the morning before
surgery; the cohort originally included 30 patients, but
only 10 of them were randomly selected for inclusion
in the present study to maintain balance between
volunteers and surgical patients [13].
Study 4 included 23 patients who underwent open
radical cystectomy and urinary diversion under general
anesthesia combined with thoracic epidural analgesia.
Baseline fluid maintenance of 1 mL kg− 1 h− 1 of Ringer’s
until the end of the removal of the bladder and
thereafter increased to 3 mL kg− 1 h− 1 of Ringer’s until
the end of surgery. A fixed dose of 20% albumin
solution (3 mL kg− 1; Albumin CSL 20%, CSL Behring,
Bern, Switzerland) was given over 30 min until removal
of the bladder (expected blood loss of > 500 mL) was
started. Blood loss was replaced with the Ringer
solution in a 1:1 ratio. A supportive administration of
norepinephrine, starting at a rate of starting at 30 ng
kg− 1 min− 1 (to maintain the mean arterial blood
pressure at > 65 mmHg) and mini fluid challenges of
100 mL of Ringer’s (to maintain the hemodynamics
pulse pressure variation > 10), until normovolemia was
restored [14]. One unit of erythrocytes was transfused,
but this was administered after data collection had
been completed.
Study 5 comprised healthy volunteers who ingested
500 mL of isotonic saline by mouth [15].
Table 1 shows the details and characteristics of the five
cohorts, which have been published with other study
questions. Precise inclusion and exclusion criteria were
given for the respective studies [11–15], but subjects with
clinically apparent hemodynamic, hepatic, renal, or pul-
monary impairment were not included in any of them.
Repeated non-invasive measurements of Hb and the
perfusion index in the hand were obtained from a pulse
oximeter (Radical 7, Masimo Corp., Irvine, CA). At the
same points in time, a blood sample was obtained for
later measurement of the Hb concentration at the hospi-
tal’s official chemical laboratory with a coefficient of
variation of approximately 1.0%. Blood gas machines
were not used.
Linear relationships
Linear relationships were evaluated by comparing non-
invasive and invasive Hb on a regression plot. The scat-
ter was used as the measure of precision and expressed
as the coefficient of determination (r2) of the regression
line. The coefficient of determination is the fraction of
the variability of y (non-invasive Hb) that can be ex-
plained by x (invasive Hb). A high r2 is desirable, as it
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implies that data scattering around the regression line is
small.
Whether the non-invasive decreases as much as the
invasive Hb during hemodilution is a different issue. We
use the slope, i.e. the steepness, of the regression line
between these two variables to express the accuracy of a
series of non-invasive measurements in the same subject.
A slope lower than 1.0 means that the numerical change
in non-invasive Hb is less than that for the invasive Hb.
Values higher than 1.0 denote the opposite relationship.
Volume kinetics
The kinetics of the infusion fluid was studied by a mixed
model approach on the non-invasive and invasive data
separately. The first three were included while the fourth
was excluded due to the large hemorrhage (median 950
mL) and the use of two infusion fluids. The fifth was
also excluded because the oral ingestion of fluid would
necessitate the use of a structurally different kinetic
model than was used for the other studies.
The model had two dependent variables, the total
urinary excretion and frequently measured plasma dilu-
tion. The latter was derived as the hemodilution divided
by (1–baseline hematocrit). In turn, the hemodilution
had been obtained as (Hbo–Hb)/Hb, in which Hbo is the
baseline value and Hb denotes measurements taken at a
later time.
The model has been created to reflect body physiology.
Vc is thought to correspond to the plasma from which
distribution and redistribution occurs to an extravascular
space, Vt. Hence, a two-volume kinetic model with rate
constants for distribution and re-distribution (k12 and
k21), one route of elimination (k10), and one scaling fac-
tor between dilution and volume (Vc, central volume)
was fitted to two dependent variables in all experiments
on a single occasion, using the Phoenix software for
nonlinear mixed effects, version 1.3 (NLME, Pharsight,
St. Louis, MO). All flows are proportional to the value of
the rate constant to the volume expansion of a fluid
space, being Vc for k12 and k10, and Vt for k21. The esti-
mate of k10 was stabilized by the measured urinary ex-
cretion, as described elsewhere [11–13]. The search
routine used was the First-Order Conditional Estimation
Extended Least Squares (FOCE ELS).
Statistics
Data are reported as the median (25th to 75th percent-
ile) and kinetic parameters as the best estimate and 95%
confidence interval. The agreement between the two
modes of measuring Hb was illustrated by Bland-Altman
plots that showed the mean difference (the agreement)
and the associated 95% limits of agreement (i.e., ± 2
standard deviations of the differences). Point-wise com-
parisons been non-invasive and invasive Hb measure-
ments has previously been reported from three of the
five case series [11–13].
Relationships were studied by simple linear regression,
where r2 = the coefficient of determination (the “scatter”
of the data).
The number of experiments was set at 60, which was
felt to be an appropriate number for outlining the rela-
tionship between non-invasive and invasive Hb. Power
analysis was applied in the respective studies. P < 0.05
was statistically significant.
Table 1 Demographics and characteristics of the studied patient groups
Study 1 Study 2 Study 3 Study 4 Study 5
Subjects Volunteers Volunteers Before major surgery During open cystectomy Volunteers
N 10 10 10 23 10
Males / females 10 / 0 10 / 0 7 / 3 19 / 4 7 / 3
Age, years 22 (18–28) 22 (19–37) 64 (29–82) 69 (67–75) 33 (10)
Body weight, kg 79 (65–101) 80 (75–100) 79 (70–87) 87 (64–90) 77 (13)
Infused Ringer’s acetate Ringer’s acetate Ringer’s acetate 20% albumin +
Ringer’s lactate
Isotonic saline
Amount, time 20mL/kg 10 ml/kg 5 mL/kg 3 mL/kg + 2100 mL 500mL
Infusion time (min) 30 20 15 300 2–3 min
Hemorrhage (mL) 0 0 0 950 (700–1225) 0
Sampling points (N) 25 16 9 14 10
Duration (min) 180 120 70 300 120
Reference 11, 16 2, 12 13 14 15
Ethics approval, city Stockholm, SE Linköping, SE Linköping, SE Bern, CH Linköping SE
Ethics approval, Nr 2009/1091–31/2 M114–09 2011/101–31 2018–02351 2010/241–31
ClinicalTrials.gov NCT01195025 NCT01062776 NCT01458678 NCT03848507 NCT01360333
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Results
At baseline, a statistically significant correlation was ob-
served between the invasive and non-invasive measure-
ment of Hb (Fig. 1a). The mean difference was only +
0.5 g L− 1, but the 95% limits of agreement ranged from
− 20 to + 21 g/L (Fig. 1b).
Maximum and minimum Hb
The highest invasive Hb measured in the 63 patients
was 136 (121–144) g L− 1 and the lowest 117 (107–130)
g L− 1. For the non-invasive Hb, these values were 131
(123–141) g L− 1 and 117 (105–126) g L− 1, respectively
(Table 2). The difference between highest and lowest
was quite similar for the two modes of measuring Hb, at
14 (10–21) vs. 15 (11–20) g L− 1. Hb was ≤100 g L− 1 in
90 of the 915 invasive measurements (10%).
In the subsequent presentation, we refrain from
making point-wise comparison between the two
technologies but focus on the linearity between their
relative changes in a series of measurements in the
same subject when Hb is deliberately changed. The
results are expressed as the scatter (precision) and
slope (accuracy) of non-invasive Hb to indicate the
invasive Hb.
Fig. 1 a The invasive versus non-invasive Hb concentration at the onset of the infusions. b Bland-Altman plot of the data shown in the previous
subplot. c Relationship between the median “scatter” around the regression lines for each of the five groups, i.e. the coefficient of determination
Table 2 Comparisons between non-invasive and invasive Hb
Study 1 Study 2 Study 3 Study 4 Study 5
Invasive Hb
Highest Hb (g/L) 144 (142–145) 138 (132–144) 123 (113–136) 129 (116–140) 138 (132–149)
Lowest Hb (g/L) 127 (124–130) 128 (122–134) 114 (104–121) 107 (97–113) 134 (126–136)
Highest – lowest Hb (g/L) 16 (16–19) 10 (9–11) 11 (9–14) 24 (16–28) 5 (5–6)
Maximum change (%) 13 (13–15) 8 (7–9) 10 (7–12) 22 (14–27) 4 (3–5)
Patient mean dilution (%) 7.0 (5.2–7.8) 3.9 (2.9–5.4) 4.2 (3.4–6.7) 11.5 (6.7–14.3) 2.9 (1.4–2.7)
Non-invasive Hb
Highest SpHb (g/L) 139 (131–149) 134 (130–141) 126 (111–137) 123 (117–136) 134 (130–150)
Lowest SpHb (g/L) 118 (109–126) 117 (111–122) 108 (99–120) 112 (96–124) 126 (123–139)
Perfusion index (%) 5.2 (3.0–7.5) 7.9 (5.7–8.9) 5.0 (2.5–5.7) 3.2 (2.1–3.5) 4.1 (2.6–6.4)
Highest – lowest Hb (g/L) 21 (19–25) 19 (14–20) 15 (11–19) 13 (7–23) 10 (8–11)
Maximum change (%)) 17 (15–24) 15 (12–18) 13 (9–16) 11 (6–21) 8 (7–8)
Patient mean dilution (%) 8.6 (6.5–10.8) 5.3 (2.0–7.8) 2.4 (0.4–5.2) 4.3 (3.5–8.9) 0.2 ((−0.8)–0.7)
Comparisons
Scatter (r2) Hb values 0.43 (0.22–0.61) 0.40 (0.25–0.63) 0.20 (0.05–0.44) 0.72 (0.48–0.81) 0.20 (0.07–0.37)
Slope Hb values 0.95 (0.79–1.12) 1.04 (0.90–1.39) 0.46 (0.37–0.77) 0.49 (0.36–0.72) 0.16 ((−0.72)–0.70)
Slope Hb dilution 0.96 (0.75–1.14) 1.06 (0.72–1.73) 0.43 (0.32–0.78) 0.38 (0.29–0.81) 0.16 ((−0.72)–0.49)
Difference Hb dilution Invasive - non-invasive −1.1 ((−3.6)–0.2) −1.1 ((3.4)–1.9) 1.2 ((− 0.1)–6.0) 6.0 (2.4–9.7) 1.6 ((− 0.1)–3.6)
Data is the median (25th–75th percentile range)
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Scattering
Overall, 46 (22–72)% of the changes of non-invasive Hb
could be explained by changes in invasive Hb, i.e. the
median “scatter” (r2) was 0.46. However, variability be-
tween the studies was considerable; the data were most
closely assembled around the regression line during
major surgery, r2 being 0.72 (Table 2).
As a rule, the scatter decreased with the Hb range in
each series; a greater difference between the highest and
lowest invasive Hb led to a higher r2 for the relationship
between the two variables (Fig. 1c).
Slope
The regression slope shows how much of a change in in-
vasive Hb is indicated by non-invasive Hb on the average
during an entire experiment. The non-invasive Hb could
either underestimate (weak slope, < 1.0), predict well
(good slope = 1.0), or overestimate (steep slope, > 1.0),
respectively, the hemodilution given by the invasive Hb.
Figure 2 shows three individual experiments where the
slope factor for the regression was weak, good, and
steep.
Overall, the slope factor was 0.57 (0.33–1.01) but it
differed greatly depending on the presence of surgical
stress, being 1.00 (0.80–1.14) in the volunteer studies
and 0.48 (0.37–0.73) in in association with surgical stress
(studies 3 and 4; P < 0.006).
In Study 4, the surgical hemorrhage volume was 950
(780–1225) mL and did not correlate with the data scat-
tering or with the slope factor.
Hemodilution
Figure 3 compares all invasive and non-invasive hemodi-
lution measurements in each sub-study. The patient
mean hemodilution was 6.0 (3.5–10.3)% for the invasive
and 4.9 (1.3–8.0)% for the non-invasive technologies
(P < 0.01).
The non-invasive Hb underestimated the hemodilu-
tion given by the invasive Hb in the surgical stress stud-
ies, but not the volunteer studies; the difference between
the patient mean hemodilution, as given by invasive and
non-invasive Hb, was − 0.1 (− 2.4 to + 2.5)% in the vol-
unteer studies but + 4.2 (1.0–8.3)% in the studies associ-
ated with surgical stress (P < 0.001).
Figure 4a compares, in each subject, the relationship
between the mean hemodilution as given by invasive
and non-invasive Hb.
Figure 4b shows the distribution of subjects between
ranges of slope factors.
Low perfusion index
Only 15 of the 915 points of measurement (1.6%) were
performed in the presence of a perfusion index of 1.0 or
lower, and these low values occasionally distorted the
data in Study 1 and 4 (Fig. 3f, Fig. 5).
Volume kinetics
Fitting the two-volume kinetic model to the data on
plasma dilution and urinary excretion was successful for
both the invasive and the non-invasive methods (Fig. 6a-
c). The precision of the kinetic parameters was higher
for the invasive Hb than for the non-invasive Hb
(Table 3), and more outliers became apparent when the
kinetic parameters were used to re-create the dependent
variables (Fig. 6d and e).
The best estimates of all parameters, as shown in
Table 3, were used to simulate the outcome of fictious
infusions. Those plots showed that the simulated expan-
sion of the plasma volume was smaller when the non-
invasive Hb was used — a difference that can be
Fig. 2 Three experiments with different slopes. Distances between the marks are set equal in each subplot to facilitate comparison. a Flat slope.
The non-invasive Hb changes much less than the invasive Hb. b Normal slope. The rise in non-invasive Hb is similar to the rise of the invasive Hb.
c Steep slope. Greater increase in non-invasive Hb than for the invasive technology
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explained by the combination of higher k12 and lower
k21 (Fig. 6f).
Discussion
The five evaluated cohorts indicate the possibilities and
limits of measuring Hb non-invasively. Overall, the dif-
ference between the highest and lowest Hb values was
quite similar between the two technologies but, as
shown many times before, there were wide limits of
agreement at the baseline. Nevertheless, changes in Hb
measured by the pulse oximeter often followed quite
well the trends yielded by invasive measurement. How-
ever, this was not a universal finding. The non-invasive
technique showed good precision but underestimated
the magnitude of the invasive Hb changes in the pres-
ence of pre-surgical or surgical stress. By contrast, the
precision was poor but the accuracy good in the volun-
teer studies.
Surgical setting versus non-stressed volunteers
The clinical question of whether erythrocytes should be
transfused was most real in Study 4 where measure-
ments were performed during major surgery. The blood
loss during the data collection amounted to almost 1 l,
and the patients received both Ringer’s and 20% albu-
min. Norepinephrine infusion was used to maintain the
arterial pressure. The hemodilution was twice as large as
that seen in any of the other studies.
The non-invasive Hb followed the trends observed in
the invasive Hb quite well, with an overall r2 as high as
0.72 despite occasional outliers that were sometimes due
to a low perfusion index. One should note that 0.72 is
the mean linearity from individual analysis of each pa-
tient, whereas the r2 yielded by point-wise comparisons
based on the pooled data from all patients in Study 4
was considerably lower, only 0.27. Importantly, the mag-
nitude of the hemodilution changes was underestimated,
and it usually amounted to only half of the invasive value
(Fig. 3d).
The underestimation of the hemodilution by the non-
invasive approach is shared by Study 3, which was
performed in patients awaiting major open abdominal
surgery. The fact that the two clinical studies show the
same pattern — namely, a too small hemodilution indi-
cated by the non-invasive Hb and, hence, a low slope
factor — suggests that adrenergic stress limits the mag-
nitude of the Hb changes detected by the non-invasive
technology, albeit without distorting the trend over time.
Fig. 3 Relationship between the hemodilution as calculated from the invasive versus the non-invasive Hb measurements in the five studies (a to
e) and the correlation between perfusion index and the deviation between the two modes of measuring Hb in a single patient from Study 4
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Studies 1 and 2 were both performed in a similar way
in volunteers, but using different amounts of crystalloid
fluid. Both studies had slopes with a median value close
to 1.0, and the non-invasive hemodilution was approxi-
mately 20% greater than that obtained with the invasive
Hb. Hence, the relationship between the two modes of
measurement was opposite to that obtained in the peri-
operative setting, which supports the notion that data
obtained in volunteers cannot be uncritically assumed to
be valid in stressful situations.
By contrast, the performance of the non-invasive
technology with oral administration of fluid was
disappointing. Here, non-invasive measurement usu-
ally showed no change at all, or a trend opposite to
that obtained by the invasive Hb. However, the aver-
age hemodilution obtained by invasive sampling
averaged only 3%, which then seems too small to
overcome the between-subject variability of the non-
invasive Hb technique to any reasonable degree.
Volume kinetics
Another issue is whether non-invasive monitoring can
be used for the study of fluid population kinetics. For
this purpose, the Hb data had to be converted to plasma
dilution, which attains values that are approximately
twice as large as the hemodilution. Previous studies have
Fig. 4 a Hemodilution as obtained by the invasive Hb versus the
non-invasive Hb for each patient. b Distribution of slope factors in
the five studies
Fig. 5 The perfusion index versus the difference in hemodilution as
obtained by the two modes of measuring Hb in (a) Study 1 and (b)
Study 4. These were the only cohorts in which the perfusion index
occasionally dropped below 1.0
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used non-invasive Hb for kinetic analysis in a two-stage
approach, but with limited success [2, 12]. Here, all ap-
propriate curves were analyzed in one single run, which
offers a more stable output.
The analysis shown in Fig. 6 reveals that fitting
the commonly used two-volume kinetic model to the
present data produced more outliers and less precise
estimates of the model parameters when based on
the non-invasive as compared to the invasive tech-
nology. In our fictitious fluid experiment, the differ-
ence between the modes of measuring Hb became
apparent during the distribution phase but not dur-
ing infusion.
Present report versus the literature
Many previous studies have examined the methodo-
logical bias by making point-wise comparisons between
invasive and non-invasive measurements of Hb, usually
without separating intra- and inter-individual differ-
ences. Some studies show a bias of 1–2% [1–4], while
studies in cardiac and emergency care report underesti-
mations of the invasive Hb of as much as 12–18 g L− 1 by
the non-invasive technique [5–7]. These results support
our observation that changes in non-invasive Hb become
too small in stressed settings. The precision has consist-
ently been poor, with 95% limits of agreement being in
the range of 40–50 g L− 1 [3, 8], or even wider [4–7]. The
Fig. 6 Volume kinetics. Curve-fitting of the Hb data from Studies 1–3 as obtained by the (a) invasive and (b) non-invasive measurements. c
Schematic drawing of the kinetic model. d The model-predicted versus the measured plasma dilution as obtained with the (d) invasive and (e)
non-invasive Hb. f Simulation of the volume expansion of the central body fluid space (the plasma) when 1 L of Ringer’s acetate is infused
over 30 min
Table 3 Population kinetic parameters
Kinetic parameter Measurement route Best estimate 95% CI CV%
Vc (L) Invasive 3.91 3.27–4.56 8.5
Non-invasive 3.11 2.51–3.71 9.8
k12 (10
− 3 min− 1) Invasive 38.3 30.9–46.0 10.0
Non-invasive 47.0 22.0–72.0 27.1
k21 (10
−3 min− 1) Invasive 23.5 14.0–32.9 20.5
Non-invasive 11.2 (−18.5)–41.0 135.2
k10 (10
−3 min−1) Invasive 9.1 3.7–14.3 29.8
Non-invasive 9.4 2.7–16.1 36.5
Data are based on 30 infusion experiments (Studies 1, 2 and 3)
CI confidence interval, CV between-subject coefficient of variation
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conclusion in a meta-analysis of 32 studies from 2016
confirmed that the mean difference between the two
modes of measuring Hb is small, while the range be-
tween the 95% limits of agreement is too wide to allow
clinical decisions to be based on them [1–17].
Our review does not focus on point-wise compari-
sons; rather, it emphasizes a series of Hb changes,
which we feel is more informative about the value of
this monitoring in the perioperative setting. Here, he-
modilution curves derived by the two modes of meas-
uring Hb most often showed quite similar trends, but
the many successful cases (high r2) were occasionally
interrupted by curves showing poor agreement, so as
to be misleading. Some of these were “switches” re-
main unexplained. The most stable indications were
obtained in the surgical setting, where r2 was below
0.25 in only 2/23 patients, although the non-invasive
Hb systematically underestimated the hemodilution.
The scattering was aggravated in the presence of a
very low perfusion index. By contrast, Chang et al.
[10], found the accuracy of the Radical-7 to be good
even when the perfusion index is below 1.0.
Limitations
Limitations of this analysis include that the invasive
Hb was measured in venous blood while the non-
invasive method is believed to represent arterial or
capillary Hb. However, the two sites of measurement
should not differ much in terms of Hb concentration
[18]. The five series of Hb experiments were collected
under different conditions, which are described in de-
tail elsewhere, but these differences do form the basis
of the present conclusions [11–16]. Data were col-
lected over a period of almost 10 years, during which
the algorithm for calculating non-invasive Hb is
claimed to have been improved. However, more re-
cent work on Hb during spinal surgery and liver
transplantation [10, 19] show almost identical accur-
acy and precision for the non-invasive Hb as we
reported in 2010 [2]. These authors also studied the
concordance between changes in invasive and non-
invasive Hb during surgery [10, 19]. However, we
chose to present our results differently, as we ob-
tained data at very short intervals, usually only 5–10
min, and up to 25 times per experiment.
Conclusions
Five series of Hb measurements showed that the
linearity between invasive and non-invasive Hb data
was strongest for the most pronounced hemodilution
in surgical patients, albeit the hemodilution was
underestimated. Data from volunteers yielded better
accuracy but showed more scatter (poorer precision).
Results were unreliable for hemodilution in the range
of 3–4%. The non-invasive methodology has severe
limitations, but Hb trends can be monitored relatively
well during surgery to identify the need for erythro-
cyte transfusion if. However, we recommend that
quality of the non-invasive Hb curve supported by
timely invasive measurements.
Abbreviations
CI: Confidence interval; CV: Coefficient of variation; Hb: Hemoglobin; k12: Rate
constant for fluid passing from the plasma to the extravascular fluid space;
k21: Rate constant for fluid passing from the extravascular fluid space to the
plasma; k10: Rate constant for fluid leaving the kinetic system as urine;
L: Liter; mL: Milliliter; r2: Coefficient of determination (“scatter”); SpHb: Pulse
co-oximetry hemoglobin; Vc: Size of central body fluid space; Vt : Size of
peripheral (extravascular) body fluid space
Supplementary Information




The authors are grateful to the co-authors and others who contributed to
the original papers on which the present work is based.
Authors’ contributions
RGH and JHZ planned the studies but PYW planned Study 4. The data was
collected by JHZ and co-workers and, in Study 4, by PYW. RGH made the cal-
culations and wrote the manuscript. All authors read and approved the final
manuscript.
Authors’ information
Robert G. Hahn: Researcher at Södertälje Hospital, Södertälje, Sweden:
Professor of Anesthesia and Intensive care at Karolinska Institutet at
Danderyds Hospital (KIDS), Stockholm, Sweden.
Patrick Y. Wuethrich: Clinical anesthetist at Inselspital, Bern University
Hospital, and associate professor of anesthesia at the University of Bern,
Switzerland.
Joachim H. Zdolsek: anesthesiologist at Linköping University Hospital,
associate professor at Linköping University, Linköping Sweden.
Funding
Department funds from Research Unit, Södertälje Hospital. Open Access
funding was provided by Karolinska Institutet. The funding organizations
played no role in the design, analysis, and interpretation of the data and in
writing the manuscript.
Availability of data and materials
The data used for the kinetic analysis is available as Additional file.xls (studies





Ethics approval and consent to participate
Ethical approvals were obtained by the Regional Ethics Committee of
Stockholm, Sweden, as 2009/1091–31/2 (on September 18, 2009); the
Regional Ethics Committee of Linköping, Sweden, as M114–09 (June 17,
2009), 2011/101–31 May 20, 2011), and 2010/241–31 September 29, 2010);
and by the Cantonal Ethics Committee KEK Bern, Switzerland, KEKBE ID
2018–02351 (on February 20, 2019). The corresponding registrations at
ClinicalTrials.gov were NCT01195025, NCT 01062776, NCT01458678,
NCT01360333, and NCT 03848507. All patients gave us their written informed
consent to participate.
Hahn et al. BMC Anesthesiology          (2021) 21:138 Page 9 of 10
Competing interests
RGH holds a grant from Grifols for the study of 20% albumin as infusion
fluid.
The other authors declare that they have no conflict of interest.
Author details
1Research Unit, Södertälje Hospital, Södertälje, and Karolinska Institutet at
Danderyds Hospital (KIDS), Stockholm, Sweden. 2Department of
Anaesthesiology and Pain Medicine, Inselspital, Bern University Hospital,
University of Bern, CH-3010 Berne, Switzerland. 3Department of
Anesthesiology and Intensive Care, and Department of Medical and Health
Sciences, Linköping University, Linköping, Sweden.
Received: 23 September 2020 Accepted: 19 April 2021
References
1. Macknet MR, Allard M, Applegate RL, Rook J. The accuracy of noninvasive
and continuous total hemoglobin measurement by pulse CO-oximetry in
human subjects undergoing hemodilution. Anesth Analg. 2010;111(6):1424–
6 https://doi.org/10.1097/ANE.0b013e3181fc74b9.
2. Hahn RG, Li Y, Zdolsek J. Non-invasive monitoring of blood haemoglobin
for analysis of fluid volume kinetics. Acta Anaesthesiol Scand. 2010;54(10):
1233–40 https://doi.org/10.1111/j.1399-6576.2010.02321.x.
3. Lamhaut L, Apriotesei R, Combes X, Lejay M, Carli P, Vivien B. Comparison of
the accuracy of noninvasive hemoglobin monitoring by spectrophotometry
(SpHb) and HemoCue® with automated laboratory hemoglobin
measurement. Anesthesiology. 2011;115(3):548–54 https://doi.org/10.1097/A
LN.0b013e3182270c22.
4. Miller RD, Ward TA, Shiboski SC, Cohen NH. A comparison of three methods
of hemoglobin monitoring in patients undergoing spine surgery. Anesth
Analg. 2011;112(4):858–63 https://doi.org/10.1213/ANE.0b013e31820eecd1.
5. Colquhoun DA, Forkin KT, Durieux ME, Thiele RH. Ability of the Masimo
pulse CO-oximeter to detect changes in hemoglobin. J Clin Monit Comput.
2012;26(2):69–73 https://doi.org/10.1007/s10877-012-9335-3.
6. Nguyen B-V, Vincent J-L, Nowak E, Coat M, Paleiron N, Gouny P, et al. The
accuracy of noninvasive hemoglobin measurement by multiwavelength
pulse oximetry after cardiac surgery. Anesth Analg. 2011;113(5):1052–7
https://doi.org/10.1213/ANE.0b013e31822c9679.
7. Gayat E, Bodin A, Sportiello C, Boisson M, Dreyfus JF, Mathieu E, et al.
Performance evaluation of a noninvasive hemoglobin monitoring
device. Ann Emerg Med. 2011;57(4):330–3 https://doi.org/10.1016/j.a
nnemergmed.2010.11.032.
8. Causey MW, Miller S, Foster A, Beekley A, Zenger D, Martin M.
Validation of noninvasive hemoglobin measurements using the Masimo
Radical-7 SpHb Station. Am J Surg. 2011;201(5):592–8 https://doi.org/1
0.1016/j.amjsurg.2011.01.020.
9. Berkow L, Rotolo S, Mirski E. Continuous noninvasive hemoglobin
monitoring during complex spine surgery. Anesth Analg. 2011;113(6):1396–
402 https://doi.org/10.1213/ANE.0b013e318230b425.
10. Chang FC, Lin JR, Liu FC. Validity of accuracy and trending ability of non-
invasive continuous total hemoglobin measurement in complex spine
surgery: a prospective cohort study. BMC Anesthesiol. 2019;19(1):117.
https://doi.org/10.1186/s12871-019-0790-y.
11. Hahn RG, Bergek C, Gebäck T, Zdolsek J. Interactions between the volume
effects of hydroxyethyl starch 130/0.4 and Ringer’s acetate. Crit Care. 2013;
17(3):R104 https://doi.org/10.1186/cc12749.
12. Zdolsek J, Li Y, Hahn RG. Detection of dehydration by using volume
kinetics. Anesth Analg. 2012;115(4):814–22. https://doi.org/ANE.0b013e3182
61f6ba. https://doi.org/10.1213/ANE.0b013e318261f6ba.
13. Hahn RG, Bahlmann H, Nilsson L. Dehydration and fluid volume kinetics
before major open abdominal surgery. Acta Anaesthesiol Scand. 2014;
58(10):1258–66. https://doi.org/aas.12416. https://doi.org/10.1111/aas.12416.
14. Löffel LM, Hahn RG, Engel D, Wuethrich PY. Intraoperative intravascular
effect of ringer lactated and hyperoncotic albumin during hemorrhage in
cystectomy patients. Anesth Analg. 2020; https://doi.org/10.1213/ane.
0000000000005173, Publish Ahead of Print.
15. Zdolsek J, Metander AS, Hahn R. Volume kinetic evaluation of fluid
turnover after oral intake of tap water, lemonade and saline in
volunteers. BMC Sports Sci Med Rehabil. 2016;8(1):22. https://doi.org/1
0.1186/s13102-016-0045-x.
16. Bergek C, Zdolsek JH, Hahn RG. Accuracy of non-invasive hemoglobin
(SpHb) depends on the type of infusion fluid. Eur J Anaesthesiol. 2012;
29(12):586–92 https://doi.org/10.1097/EJA.0b013e3283592733.
17. Kim SH, Lilot M, Murphy LS, Sidhu KS, Yu Z, Rinehart J, et al. Accuracy of
continuous noninvasive hemoglobin monitoring. Anesth Analg. 2016;119(2):
332–46 https://doi.org/10.1213/ANE.0000000000000272.
18. Hahn RG, Lindahl C, Drobin D. Volume kinetics of acetated Ringer’s solution
during experimental spinal anaesthesia. Acta Anaesthesiol Scand. 2011;55(8):
987–94 https://doi.org/10.1011/j.1399-6576.2011.02493.x.
19. Huang PH, Shih BF, Tsai YF, Chung PCH, Liu FC, Yu HP, et al. Accuracy and
trending of continuous noninvasive hemoglobin monitoring in patients
undergoing liver transplantation. Transpl Proc. 2016;48(4):1067–70 https://
doi.org/10.1016/j.transproceed.2015.12.121.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Hahn et al. BMC Anesthesiology          (2021) 21:138 Page 10 of 10
